These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24126887)

  • 1. Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
    Ye YW; Hu S; Shi YQ; Zhang XF; Zhou Y; Zhao CL; Wang GJ; Wen JG; Zong H
    Oncol Rep; 2013 Dec; 30(6):2777-84. PubMed ID: 24126887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer.
    Li J; Ye Y; Wang M; Lu L; Han C; Zhou Y; Zhang J; Yu Z; Zhang X; Zhao C; Wen J; Kan Q
    Tumour Biol; 2016 May; 37(5):6881-91. PubMed ID: 26662569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.
    Ye Y; Jiang D; Li J; Wang M; Han C; Zhang X; Zhao C; Wen J; Kan Q
    Tumour Biol; 2016 Mar; 37(3):3185-95. PubMed ID: 26432329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
    Jiang D; Li J; Li J; Wang M; Han C; Wang X; Zhao C; Ye Y
    Int J Oncol; 2017 Nov; 51(5):1611-1620. PubMed ID: 29048661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
    Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ
    Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803].
    Wu Q; Yu JC; Liu YQ; Kang WM; Guo WD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):65-70. PubMed ID: 20236591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.
    Wang J; Hu W; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
    Int J Oncol; 2016 Apr; 48(4):1341-52. PubMed ID: 26847910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil.
    Chen WY; Huang CY; Cheng WL; Hung CS; Huang MT; Tai CJ; Liu YN; Chen CL; Chang YJ
    Tumour Biol; 2015 Dec; 36(12):9537-44. PubMed ID: 26136123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of traditional Tibetan drug Liu Tea on proliferation and chemotherapeutic sensitivity of drug-resistant human gastric cancer cell BGC823/5-FU].
    Cheng Y; Hasiqi MG; Qin XZ; Tang XY; Chen JN; Wang HY; Gao A
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):603-608. PubMed ID: 28871679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.
    Li XL; Wang CZ; Mehendale SR; Sun S; Wang Q; Yuan CS
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1097-104. PubMed ID: 19277659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
    Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
    Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
    Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells.
    Moon JY; Cho M; Ahn KS; Cho SK
    Nutr Cancer; 2013; 65(2):286-95. PubMed ID: 23441616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chan-Yu-Bao-Yuan-Tang and 5-fluorouracil synergistically induce apoptosis by means of the caspase-3 signaling pathway in lung and cervical cancer cells.
    Zeng F; Liu X; Li Y; Chen G; Wang Y; Zhou S; Zhu W; Huang Y; Zhou J; Li S; Zhang Y
    Mol Med Rep; 2011; 4(1):113-20. PubMed ID: 21461573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 5-fluorouracil aerosol on the growth of human gastric cancer cell line MKN-45 in vitro].
    Lin T; Yu J; Wei ZG; Hu YF; Wang YN; Li GX
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1066-8. PubMed ID: 21690071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.
    Turkington RC; Longley DB; Allen WL; Stevenson L; McLaughlin K; Dunne PD; Blayney JK; Salto-Tellez M; Van Schaeybroeck S; Johnston PG
    Cell Death Dis; 2014 Feb; 5(2):e1046. PubMed ID: 24503538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.
    Lee HW; Kim SJ; Choi IJ; Song J; Chun KH
    Clin Exp Metastasis; 2015 Aug; 32(6):593-603. PubMed ID: 26134677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.